Insecticide-treated eave nets and window screens for malaria control in Chalinze district, Tanzania: a study protocol for a household randomised control trial.


Journal

Trials
ISSN: 1745-6215
Titre abrégé: Trials
Pays: England
ID NLM: 101263253

Informations de publication

Date de publication:
19 Jul 2022
Historique:
received: 05 11 2021
accepted: 19 05 2022
entrez: 19 7 2022
pubmed: 20 7 2022
medline: 22 7 2022
Statut: epublish

Résumé

Long-lasting insecticidal nets (LLINs) have contributed to the reduction of malaria in sub-Saharan Africa, including Tanzania. However, they rely on daily user behaviour and high coverage which is difficult to maintain. Also, insecticide resistance among malaria vector mosquitoes is contributing to reduced efficacy of control tools. To overcome these problems, we propose to evaluate a new tool for house modification, the insecticide-treated eave nets (ITENs) in combination with insecticide-treated window screens (ITWS) incorporated with dual active ingredient (dual AI) for the control of malaria. Four hundred and fifty (450) households with intact walls, open eaves without screens or nets on the windows in Chalinze district will be eligible and recruited upon written informed consent. The households will be randomly allocated into two arms: one with ITENs and ITWS installed and the other without. Malaria parasite detection using a quantitative polymerase chain reaction (qPCR) will be conducted shortly after the long rain (June/July, 2022) as the primary outcome and shortly after the short rain (January/February, 2022) as the secondary outcome. Other secondary outcomes include clinical malaria cases, and density of malaria vectors and nuisance after the short rain and long rain. In addition, surveys will be conducted in households with ITENs and ITWS to estimate the intervention's cost during installation, adverse effects one month after installation, and presence, fabric integrity and user acceptance six and twelve months after installation. Bioefficacy and chemical content will be evaluated twelve months after installation. ITENs and ITWS have been shown in Kenya to reduce indoor mosquito density. However, it is not known if indoor mosquito density reduction translates into reduction of malaria cases. Data from the study will measure the potential public health value of an additional intervention for malaria control at the household level in areas of mosquito insecticide resistance that does not require daily adherence. The study is registered on ClinicalTrials.gov .

Sections du résumé

BACKGROUND BACKGROUND
Long-lasting insecticidal nets (LLINs) have contributed to the reduction of malaria in sub-Saharan Africa, including Tanzania. However, they rely on daily user behaviour and high coverage which is difficult to maintain. Also, insecticide resistance among malaria vector mosquitoes is contributing to reduced efficacy of control tools. To overcome these problems, we propose to evaluate a new tool for house modification, the insecticide-treated eave nets (ITENs) in combination with insecticide-treated window screens (ITWS) incorporated with dual active ingredient (dual AI) for the control of malaria.
METHODS METHODS
Four hundred and fifty (450) households with intact walls, open eaves without screens or nets on the windows in Chalinze district will be eligible and recruited upon written informed consent. The households will be randomly allocated into two arms: one with ITENs and ITWS installed and the other without. Malaria parasite detection using a quantitative polymerase chain reaction (qPCR) will be conducted shortly after the long rain (June/July, 2022) as the primary outcome and shortly after the short rain (January/February, 2022) as the secondary outcome. Other secondary outcomes include clinical malaria cases, and density of malaria vectors and nuisance after the short rain and long rain. In addition, surveys will be conducted in households with ITENs and ITWS to estimate the intervention's cost during installation, adverse effects one month after installation, and presence, fabric integrity and user acceptance six and twelve months after installation. Bioefficacy and chemical content will be evaluated twelve months after installation.
DISCUSSION CONCLUSIONS
ITENs and ITWS have been shown in Kenya to reduce indoor mosquito density. However, it is not known if indoor mosquito density reduction translates into reduction of malaria cases. Data from the study will measure the potential public health value of an additional intervention for malaria control at the household level in areas of mosquito insecticide resistance that does not require daily adherence.
TRIAL REGISTRATION BACKGROUND
The study is registered on ClinicalTrials.gov .

Identifiants

pubmed: 35854371
doi: 10.1186/s13063-022-06408-4
pii: 10.1186/s13063-022-06408-4
pmc: PMC9295261
doi:

Substances chimiques

Insecticides 0

Types de publication

Clinical Trial Protocol Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

578

Subventions

Organisme : Medical Research Council
ID : MR/R010161/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/T003677/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/T0036771 & EPIDZR44
Pays : United Kingdom

Informations de copyright

© 2022. The Author(s).

Références

Malar J. 2018 Mar 1;17(1):100
pubmed: 29490649
Malar J. 2019 Jan 15;18(1):9
pubmed: 30646918
BMC Infect Dis. 2014 Feb 08;14:69
pubmed: 24507444
Can J Hosp Pharm. 2015 May-Jun;68(3):226-31
pubmed: 26157184
Malar J. 2019 Mar 26;18(1):102
pubmed: 30914051
Lancet Glob Health. 2021 Sep;9(9):e1325-e1331
pubmed: 34216565
Malar J. 2020 Jun 23;19(1):220
pubmed: 32576180
Cochrane Database Syst Rev. 2018 Nov 29;11:CD012776
pubmed: 30488945
Am J Trop Med Hyg. 2003 Apr;68(4 Suppl):121-7
pubmed: 12749495
Cochrane Database Syst Rev. 2021 May 24;5:CD012776
pubmed: 34027998
Am J Trop Med Hyg. 1998 Oct;59(4):595-6
pubmed: 9790436

Auteurs

Olukayode G Odufuwa (OG)

Vector Control Product Testing Unit, Ifakara Health Institute (IHI), Bagamoyo, Tanzania. oodufuwa@ihi.or.tz.
Vector Biology Unit, Swiss Tropical and Public Health Institute (SwissTPH), Allschwil, Switzerland. oodufuwa@ihi.or.tz.
University of Basel, Basel, Switzerland. oodufuwa@ihi.or.tz.
MRC International Statistics and Epidemiology Group, London School of Hygiene and Tropical Medicine (LSHTM), London, UK. oodufuwa@ihi.or.tz.

Sarah Jane Moore (SJ)

Vector Control Product Testing Unit, Ifakara Health Institute (IHI), Bagamoyo, Tanzania.
Vector Biology Unit, Swiss Tropical and Public Health Institute (SwissTPH), Allschwil, Switzerland.
University of Basel, Basel, Switzerland.

Zawadi Mageni Mboma (ZM)

Vector Control Product Testing Unit, Ifakara Health Institute (IHI), Bagamoyo, Tanzania.
MRC International Statistics and Epidemiology Group, London School of Hygiene and Tropical Medicine (LSHTM), London, UK.

Emmanuel Mbuba (E)

Vector Control Product Testing Unit, Ifakara Health Institute (IHI), Bagamoyo, Tanzania.
Vector Biology Unit, Swiss Tropical and Public Health Institute (SwissTPH), Allschwil, Switzerland.
University of Basel, Basel, Switzerland.

Joseph Barnabas Muganga (JB)

Vector Control Product Testing Unit, Ifakara Health Institute (IHI), Bagamoyo, Tanzania.

Jason Moore (J)

Vector Control Product Testing Unit, Ifakara Health Institute (IHI), Bagamoyo, Tanzania.
Vector Biology Unit, Swiss Tropical and Public Health Institute (SwissTPH), Allschwil, Switzerland.
University of Basel, Basel, Switzerland.

Rose Philipo (R)

Vector Control Product Testing Unit, Ifakara Health Institute (IHI), Bagamoyo, Tanzania.

Mohammed Ally Rashid (MA)

Vector Control Product Testing Unit, Ifakara Health Institute (IHI), Bagamoyo, Tanzania.

Rune Bosselmann (R)

Vegro Aps, Copenhagen, Denmark.

Ole Skovmand (O)

MCC47, Montpellier, France.

John Bradley (J)

MRC International Statistics and Epidemiology Group, London School of Hygiene and Tropical Medicine (LSHTM), London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH